Cargando…
(4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry
Without a vaccine, hepatitis C virus (HCV) remains a significant threat, putting 170–300 million carriers worldwide at risk of cirrhosis and hepatocellular carcinoma. Although the direct-acting antivirals targeting HCV replication have revolutionized the treatment of hepatitis C, several obstacles p...
Autores principales: | Chung, Chueh-Yao, Liu, Ching-Hsuan, Wang, Guey-Horng, Jassey, Alagie, Li, Chia-Lin, Chen, Lei, Yen, Ming-Hong, Lin, Chun-Ching, Lin, Liang-Tzung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947960/ https://www.ncbi.nlm.nih.gov/pubmed/27426693 http://dx.doi.org/10.1038/srep29969 |
Ejemplares similares
-
Methanolic Extract of Rhizoma Coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection
por: Hung, Ting-Chun, et al.
Publicado: (2018) -
Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry
por: Kuo, Yu-Ting, et al.
Publicado: (2020) -
Antiviral Activities of Silymarin and Derivatives
por: Liu, Ching-Hsuan, et al.
Publicado: (2019) -
Hepatitis C Virus Non-Structural Protein 5A (NS5A) Disrupts Mitochondrial Dynamics and Induces Mitophagy
por: Jassey, Alagie, et al.
Publicado: (2019) -
Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry
por: Lin, Liang-Tzung, et al.
Publicado: (2013)